Myovant Stock Story

MYOV -  USA Stock  

USD 20.28  0.22  1.07%

Myovant Stock News module provides quick insight into current market opportunities from investing in Myovant Sciences. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Myovant Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Additionally, see Myovant Sciences Hype Analysis, Myovant Sciences Correlation and Myovant Sciences Performance.

Search Today's Stock News 

 
Refresh
Myovant Sciences stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Myovant daily returns and investor perception about the current pice of Myovant Sciences as well as its diversification or hedging effects on your existing portfolios.
Exercise or conversion by Arjona Ferreira Juan Camilo of 1300 shares of Myovant Sciences subject to Rule 16b-3
Filed transaction by Myovant Sciences Ltd officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

MYOV Myovant insider trading alert for exercise of stock option (right to buy) by Arjona Ferreira Juan Camilo, Chief Medical Officer, on 2nd of June 2021. This event was filed by Myovant Sciences Ltd with SEC on 2021-06-02. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Myovant Sciences Fundamental Analysis

We analyze Myovant Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myovant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myovant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned by Insiders

Shares Owned by Insiders Comparative Analysis

Myovant Sciences is currently under evaluation in shares owned by insiders category among related companies. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Myovant Sciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Myovant Sciences stock to make a market-neutral strategy. Peer analysis of Myovant Sciences could also be used in its relative valuation, which is a method of valuing Myovant Sciences by comparing valuation metrics with similar companies.

Peers

Myovant Sciences Related Equities

EQ
EQEquillium   1.66   
0%
10.0%
DRNA
DRNADicerna Pharmaceutic   0.19   
1.0%
0%
DVAX
DVAXDynavax Technologies   0.86   
5.0%
0%
EDIT
EDITEditas Medicine   1.46   
9.0%
0%
DTIL
DTILPrecision Biosciences   1.56   
10.0%
0%
DYAI
DYAIDyadic International   3.64   
23.0%
0%
EDSA
EDSAEdesa Biotech   4.28   
28.0%
0%
DSGN
DSGNDesign Therapeutics   9.38   
61.0%
0%
DMAC
DMACDiamedica Therapeutics   10.03   
65.0%
0%
DNLI
DNLIDenali Therapeutics   15.27   
100.0%
0%
Additionally, see Myovant Sciences Hype Analysis, Myovant Sciences Correlation and Myovant Sciences Performance. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.